Skip to content

Sight Sciences, Inc. SGHT Net Change in Cash

Net Change in Cash at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Glaukos logo
GlaukosGKOS
$13.44M+124%
AbbVie logo
AbbVieABBV
$4.16B+1,293%
Schering-Plough logo
Schering-PloughSGP
$142.54M+242%
Bausch + Lomb logo
Bausch + LombBLCO
-$118M-16.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-$82.01M-201%

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Reported directly by Sight Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s net change in cash?
Sight Sciences, Inc. (SGHT) reported net change in cash of -$7M in Q1 2026.
How has Sight Sciences, Inc.'s net change in cash changed year-over-year?
Sight Sciences, Inc.'s net change in cash increased by 39.6% year-over-year, from -$11.59M to -$7M.
What is the long-term trend for Sight Sciences, Inc.'s net change in cash?
Over 3 years (2021 to 2025), Sight Sciences, Inc.'s net change in cash has grown at a -48.8% compound annual growth rate (CAGR), from $209.96M to -$28.13M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.